Description
LL-37 information
LL-37 is described in scientific and analytical literature as a human cathelicidin-derived host-defence peptide. Recognised terminology includes LL37, human cathelicidin antimicrobial peptide. Common terms include cathelicidin, CAMP, host-defence peptide. The relevant scientific context is cathelicidin, membrane-interaction and host-defence peptide . These terms identify the subject and should not be read as product-specific analytical evidence.
Current product specifications, price, availability, storage information and the current product image remain in the existing product panel above. Where analytical documentation is available, read it only in relation to the exact sample, batch/reference and result shown on that report. A report for another strength, batch or compound must not be presented as evidence for this product.
For broader scientific background, use the Peptide Pro profile and established literature databases where relevant. Published scientific literature provides background on LL-37; it does not authenticate a commercial batch. Useful internal routes: LL-37 profile, Peptide Pro testing and batch verification, verify the official Peptide Pro website, LL37 5mg.
Use Peptide Pro Quality & Testing and Official Website Verification to confirm the current site, documentation policy and available product-specific evidence. Related records: KPV 10mg, BPC-157 20mg, Thymosin Alpha 10mg.
